Vision News

22 September 2019

Office Details

thumb-office135 Lakeshore Rd. W.
Oakville, ON L6K 1E5
view map
  • Monday:8:30 am - 7:30 pm
  • Tuesday:8:00 am - 4:00 pm
  • Wednesday:8:00 am - 5:30 pm
  • Thursday:8:00 am - 4:30 pm
  • Friday:8:00 am - 3:00 pm

Education Center

Age-related macular degeneration (AMD) is the leading cause of blindness in people over 55 in Canada and the U.S.

The Age-Related Eye Disease Study (AREDS) was a very large study sponsored by the U.S. Federal Government's National Eye Institute. The results were published in 2001.

The AREDS2 study took place after the original AREDS study and concluded in 2014. These two studies were used to design vitamin/mineral supplements to slow the progression of AMD.

The researchers concluded that taking the AREDS formulation can reduce the risk of developing a more advanced form of AMD by about 25%.

It has more recently been determined that roughly half the patients taking the AREDS formula showed no benefit and others actually showed an accelerated progression of the disease.

While AREDS can help about 35% of patients, almost 15% of patients being treated with AREDS supplements were made worse.

How do you know if you will benefit from AREDS vitamins or be harmed by taking the formula?

In 2018 a published paper revealed the link between patients individual genetics and how they respond to different supplement formulae after analyzing the AREDS study data futher.

click here for this paper: 2018 results

Genetic testing can now be used to not only determine which vitamin formula is safe for you to take, but can also predict your indiviual risk of pregression to a more advance form of AMD.

This testing uses a sample obtained from a cheek swab and 3 weeks later the report is available.

For more information, click here: Macularisk

 

© Dr. J C Mungar | 135 Lakeshore Road West | Oakville | Ontario | L6K 1E5 | 905-842-3411 | Site Map
Text and photos provided are the property of EyeMotion and cannot be duplicated or moved.